The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for Biologics Evaluation and Research (CBER), following the exit of top vaccine ...

What's next for AI software provider Palantir amid major government spending cutbacks? Seeking Alpha analysts over their ...

The general mood among these heavyweight investors is divided, with 40% leaning bullish and 50% bearish. Among these notable ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

The healthcare sector, as measured by Health Care Select Sector SPDR Fund (NYSEARCA:XLV), with 12.12% weightage on the S&P ...

(“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX ® is the #1 recommended iron supplement brand in Canada, based on a national survey of Canadian pharmacists and physicians (1). This ...

The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.

"The DEA's marijuana approach is stuck in an outdated ‘war on drugs' mentality," said Duane Boise CEO of MMJ International Holdings. "While lawmakers push for medical progress, the DEA's red tape is ...

Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025 ...

ConferenceHeidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025 26.03.2025 / 09:23 CET/CESTThe issuer is solely responsible for the content of this ...

We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options ...

Ladenburg, Germany, 21 March 2025 – Heidelberg Pharma AG (FSE: HPHA) today published its financial results and Annual Report for fiscal year 2024 (1 December 2023 – 30 November 2024) and its outlook ...